Gyre Therapeutics, Inc.
GYRE
$6.68
$0.142.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 74.80M | 49.81M | 52.43M | 60.05M | 54.37M |
| Total Receivables | 28.25M | 26.81M | 36.95M | 26.80M | 25.36M |
| Inventory | 11.43M | 11.35M | 10.17M | 8.85M | 8.86M |
| Prepaid Expenses | 7.60M | 3.76M | 1.34M | 2.87M | 2.70M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 1.49M | -- | -- |
| Total Current Assets | 122.07M | 91.73M | 102.37M | 98.58M | 91.29M |
|
|
|||||
| Total Current Assets | 122.07M | 91.73M | 102.37M | 98.58M | 91.29M |
| Net Property, Plant & Equipment | 30.56M | 23.57M | 24.73M | 24.91M | 24.90M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.53M | 4.63M | 6.15M | 4.85M | 4.96M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.85M | 10.97M | 7.77M | 10.74M | 9.97M |
| Total Assets | 199.26M | 162.02M | 166.13M | 159.38M | 152.65M |
|
|
|||||
| Total Accounts Payable | 1.24M | 265.00K | 124.00K | 556.00K | 71.00K |
| Total Accrued Expenses | 16.08M | 13.30M | 12.09M | 9.46M | 12.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.39M | 751.00K | 636.00K | 626.00K | 622.00K |
| Total Finance Division Other Current Liabilities | 9.96M | 5.47M | 5.44M | 5.27M | 3.49M |
| Total Other Current Liabilities | 9.96M | 5.47M | 5.44M | 5.27M | 3.49M |
| Total Current Liabilities | 28.66M | 19.79M | 18.29M | 15.91M | 16.92M |
|
|
|||||
| Total Current Liabilities | 28.66M | 19.79M | 18.29M | 15.91M | 16.92M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.03M | 72.00K | 303.00K | 539.00K | 771.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.64M | 5.17M | 5.26M | 5.52M | 5.51M |
| Total Liabilities | 34.34M | 25.03M | 23.85M | 21.97M | 23.20M |
|
|
|||||
| Common Stock & APIC | 240.75M | 174.74M | 172.14M | 167.23M | 161.53M |
| Retained Earnings | -134.31M | -74.02M | -65.33M | -63.61M | -67.22M |
| Treasury Stock & Other | 1.49M | 586.00K | -779.00K | -1.70M | -2.29M |
| Total Common Equity | 107.93M | 101.31M | 106.03M | 101.92M | 92.03M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 22.43M | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 22.43M | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 107.93M | 101.31M | 106.03M | 101.92M | 92.03M |
| Total Preferred Equity | 22.43M | -- | -- | -- | -- |
| Total Minority Interest | 34.56M | 35.68M | 36.25M | 35.50M | 37.42M |
| Total Equity | 164.92M | 136.99M | 142.28M | 137.42M | 129.44M |
|
|
|||||